 10. Either symptomatic or clinically active brain metastases ie, requiring ongoing treatment. Patients are eligible if brain metastases are adequately treated. Patients must be either off corticosteroids, or on a stable or decreasing dose of 10 mg daily prednisone or equivalent. 